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Alternative cassette exons are known to originate from two processes—exonization of intronic sequences and exon
shuffling. Herein, we suggest an additional mechanism by which constitutively spliced exons become alternative
cassette exons during evolution. We compiled a dataset of orthologous exons from human and mouse that are
constitutively spliced in one species but alternatively spliced in the other. Examination of these exons suggests that
the common ancestors were constitutively spliced. We show that relaxation of the 59 splice site during evolution is one
of the molecular mechanisms by which exons shift from constitutive to alternative splicing. This shift is associated with
the fixation of exonic splicing regulatory sequences (ESRs) that are essential for exon definition and control the
inclusion level only after the transition to alternative splicing. The effect of each ESR on splicing and the combinatorial
effects between two ESRs are conserved from fish to human. Our results uncover an evolutionary pathway that
increases transcriptome diversity by shifting exons from constitutive to alternative splicing.
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Introduction
Splicing is a mechanism by which mature mRNA is formed
through the removal of introns from the pre-mRNA and the
ligation of exons. Four short sequences define an intron: the
59 and 39 splice sites (59ss and 39ss), the branch site (BS), and
the polypyrimidine tract (PPT) [1]. Alternative splicing is a
process by which more than one mRNA is produced from the
same pre-mRNA [2,3]. Alternative splicing events are classi-
fied into four main subgroups: (i) removal of alternative
cassette exons (also called exon skipping), when an exon and
flanking introns are spliced out of the transcript; (ii) use of
alternative 59ss or (iii) 39ss, resulting from recognition of two
or more splice sites at one end of an exon; and (iv) intron
retention, in which an intron remains in the mature mRNA
molecule [4,5]. In mammals, a large fraction (40%–80%) of
the genes undergoes alternative splicing, but no alternative
splicing has been reported in Saccharomyces cerevisiae or S.
pombe [6]. Thus, alternative splicing is believed to be a major
source of the phenotypic complexity in higher eukaryotes
[2,7]. The recent availability of genomes and transcriptomes
provides data for the study of the evolution of alternative
splicing.
Several large-scale bioinformatic studies have examined
the evolution of alternative splicing. One of the primary
works demonstrated that alternative cassette exons with a
high inclusion level are usually conserved between human
and mouse (i.e., they are found in both genomes), but that
alternative cassette exons with a low inclusion level are often
not conserved [8]. Additionally, these low-inclusion alter-
native cassette exons most likely originated from unique
intronic sequences [9]. Previous studies demonstrated that
homologous exons that are spliced differently in human and
mouse, termed species-specific exons, represent at least 11%
of the human–mouse alternative cassette exons and exhibit a
high inclusion level, presumably reflecting their evolutionary
history. These exons probably have an important role in the
evolutionary differences among mammalian species [10,11].
These results are indicative of the dynamic evolution of
alternative cassette exons and their major contribution to
genome structure and transcriptomic diversity.
But how did alternative splicing evolve? One known
mechanism for generating new alternative cassette exons is
exon shuffling, in which a new exon is inserted into an
existing gene or an exon is duplicated within the same gene
[12–14]. Alternative cassette exons can also emerge following
exonization of intronic sequences; about 4%–5% of human
genes contain transposable element motifs in their coding
regions [15–19]. These newly inserted exons typically exhibit
a low inclusion level, thus maintaining the evolutionary
conserved isoform as the main mRNA product [6].
In the two mechanisms described above, the alternative
cassette exons are added to existing genes. However, a third
mechanism was recently proposed, in which alternative exons
are derived from constitutively spliced ones [6]. Recently, we
demonstrated that alternative 39 and 59 exons can originate
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from constitutively spliced exons by the generation of a
competing splice site, either within the exon or in one of the
flanking introns, thus generating new exons from constitutive
exons [20]. Here, we provide computational and experimental
evidence supporting the hypothesis that alternative cassette
exons can also originate from constitutively spliced exons. A
dataset of human–mouse exons that are spliced in a species-
specific manner was compiled. Bioinformatic analysis of these
exons using expressed sequence tags (ESTs) from mammalian
and nonmammalian organisms suggests that the common
ancestors of species-specific alternatively spliced exons (AS
exons) were constitutively spliced exons. The reliability of the
EST analysis was confirmed experimentally. The alternatively
spliced, species-specific AS exons had a high inclusion level,
presumably to ensure synthesis of the ancient spliced form
(exon inclusion) as the major mRNA product. Relaxation of
59ss selection was shown to be involved in the evolutionary
shift from constitutive to alternative splicing. The transition
to alternative splicing was associated with fixation of exonic
splicing regulatory sequences (ESRs) that control the inclu-
sion/skipping ratio in alternative splicing. The effect of each
ESR on splicing and the combinatorial effects between two
ESRs are conserved among zebrafish, chicken, mouse and
human. Our results support the existence of an evolutionary
pathway that increases transcriptome diversity by shifting
exons from constitutive to alternative splicing.
Results
Conserved Species-Specific Exons Contain Characteristics
of Constitutive Exons
We compiled three datasets containing orthologous exons
from human and mouse and their flanking introns [21]: exons
constitutively spliced in both species (45,553), alternative
cassette exons in both species (596), and species-specific
exons (612). In the species-specific exon dataset, 354 and 258
exons are alternatively spliced in human and mouse,
respectively.
Certain characteristics distinguish alternatively spliced
from constitutively spliced exons [11,22–25]. Based on these
characteristics, we performed a large scale analysis using 15
parameters to test whether species-specific AS exons were
more similar to constitutively spliced exons or alternative
cassette exons (Figure 1A). Our results showed that in 14 out
of the 15 tested characteristics, the species-specific AS exons
were more similar to the constitutively spliced exons than to
the alternative cassette exons (Figure 1A and Table S1). For
example, constitutively spliced exons exhibited a high degree
of exon sequence conservation (termed the identity level) of
87.8%, whereas alternative cassette exons that exhibited a
92.2% identity level. The average conservation level between
species of species-specific exons was 88.3%, similar to that of
constitutively spliced exons. Although the species-specific AS
exons differed significantly from constitutively spliced exons
in the tested characteristics (Mann-Whitney, p value ¼ 0.04),
the difference was much more significant when compared
with alternative cassette exons (Mann-Whitney, p value ¼
631034; see Table S1 for all tested parameters and p values).
A ratio between nonsynonymous and synonymous sub-
stitution rates (Ka/Ks ratio) test was previously proposed for
detecting exons in genomic regions [26]. Xing and Lee (2005)
showed that this method efficiently detects exons that are
constitutively spliced but is less efficient in the case of
alternative cassette exons [27]. This observation suggests that
this ratio test can also be used to distinguish constitutively
spliced exons from alternatively spliced ones. We note that
this test differs from the Ka/Ks ratio, as it takes into account
the standard error in the Ka/Ks estimates (i.e., it statistically
tests whether the exon evolves). As expected, constitutively
spliced exons were found to be significantly different from
alternatively spliced ones: the percentage of exons that failed
the Ka/Ks ratio test was 7.6% and 33.3% for constitutively and
alternative cassette exons, respectively (Fisher Exact, p value
, 4.231050). In agreement with our results above, the Ka/Ks
ratio test on the species-specific AS exons resulted in 13.5%
failure, indicating a high similarity to constitutively spliced
exons. Statistically, the AS exons differed significantly from
constitutive exons (Fisher Exact, p value¼1.83106). However,
the difference was much larger when compared to alternative
exons (Fisher Exact, p value¼ 2.231013) (Figure 1A).
Since we had established that the species-specific AS exons
were more similar to constitutive exons than to alternative
cassette exons, we next tested whether the flanking intronic
sequences also showed this tendency. We demonstrated
previously that intronic sequences flanking alternative
cassette exons conserved in human and mouse are more
conserved than constitutively spliced exons [28]. We found
that an average of 119.4 nucleotides upstream and 117.4
nucleotides downstream of exons could be aligned in
constitutively spliced exons, compared with 233.4 and 224.7
in alternative cassette exons (p value ¼ 0 and p value ¼ 0 for
upstream and downstream introns, Mann-Whitney test). The
intronic sequence alignment of the species-specific AS exons
are very similar to the results of constitutively spliced exons:
125.5 and 116.6 nucleotides could be reliably aligned up-
stream and downstream of exons, respectively (Figure 1A and
1B). The species-specific AS exons did not statistically differ
from constitutively spliced exons (p value¼ 0.085 and p value
¼ 0.39 for upstream and downstream introns, Mann-Whitney
test), but significantly differed from alternative cassette exons
(p value ¼ 2.5831052 and p value ¼ 1.4731058 for upstream
and downstream introns, Mann-Whitney test).
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Author Summary
Alternative splicing is believed to play a major role in the creation of
transcriptomic diversification leading to higher order of organismal
complexity, especially in mammals. As much as 80% of human
genes generate more than one type of mRNA by alternative splicing.
Thus, alternative splicing can bridge the low number of protein
coding genes (;24,500) and the total number of proteins generated
in the human proteome (;90,000). The correlation between the
higher order of phenotypic diversity and alternative splicing was
recently demonstrated and thus the origin of alternative splicing is
of great interest. There are currently two models regarding the
origin of alternatively spliced exons—exonization of intronic
sequences and exon shuffling. According to these two mechanisms,
a protein-coding gene was first established and only then a new
alternative exon appeared within it or was added to the gene. Our
current study provides evidences for a new mechanism indicating
that during evolution constitutively spliced exons became alter-
natively spliced. Large-scale bioinformatic analyses reveal the
magnitude of this process and experimental validation systems
provide insights into its mechanisms.
ESRs are short exonic sequence motifs that regulate
splicing. Conservation of these elements is different in
constitutive and alternative cassette exons [29]. Thus, we
compared the conservation level in human and mouse
sequences of 285 putative ESRs in our three datasets (Figure
1C). As expected, ESRs were significantly more conserved in
alternative cassette exons compared with constitutively
spliced exons (65.9% and 52.3% conservation, respectively;
v2, p value ¼ 9.631092). The species-specific AS exons
exhibited a 52.4% conservation level of the ESRs, which is
statistically insignificant with respect to constitutively spliced
exons, but statistically significant with respect to alternative
cassette exons (v2, p value ¼ 3.231056). Figure 1A–1C show
that the species-specific AS exons are more closely related to
constitutively spliced exons, in 14 out of 15 different
characteristics, than to alternative cassette exons.
High Inclusion Level of Species-Specific AS Exons
The alternative variant of species-specific spliced exons is
either the ancestral form or the derived one. To distinguish
between these two possibilities, the splicing pattern of exons
that are orthologous to the species-specific AS exons was
analyzed experimentally. We selected orthologous exons that
are alternatively spliced in human and constitutively spliced
in mouse, for which orthologous exons and the conserved
flanking exons could be identified using the HomoloGene
database for six different organisms—human, mouse, rat,
dog, chicken, and zebrafish. Ten exons were initially
evaluated (Table S2). In five cases, the orthologous exons
and the conserved flanking exons were found in all six
organisms. For each orthologous exon, pairs of primers were
designed to hybridize in flanking exons to amplify a PCR
product of similar size for the exon-inclusion isoform in all
organisms. Total RNA was extracted from brain tissues of
human, mouse, rat, and dog, and from the entire organism of
chicken and zebrafish. The RNA was analyzed by reverse
transcription-PCR (RT-PCR) and by sequencing of all PCR
products. Similar results were obtained when RNA was
extracted from different cell lines from human, mouse, and
rat (see Text S2).
Figure 1. Species-Specific Exons Exhibit Characteristics of Constitutive Exons
(A) Fifteen different characteristics that differentiate constitutively spliced exons from alternative cassette exons were examined on orthologous human
and mouse exons that are constitutively spliced in one species but alternatively spliced in the other. We examined exon sequence conservation level
between human and mouse (Identity), exon lengths (Length), percentage of exons in which the total number of nucleotides was divisible by 3
(Symmetrical), U1/59ss binding strength (DG), the ratio between nonsynonymous and synonymous substitution rates (Ka/Ks), synonymous substitutions
rate (Ks), the fraction of exons that fail the Ka/Ks likelihood ratio test (Fail Ka/Ks), the conservation of ESRs along the exons (ESR cons), the size of the
flanking introns stretches that could be reliably aligned to the mouse ortholog for both upstream and downstream intron (Stretch up and Stretch down,
respectively), the average size of the upstream and downstream introns (Intron up and Intron down, respectively), and the inclusion level of the exons
(Inclusion). (B) Conservation level of the flanking intronic sequences. Median conservation level at each base position was calculated for the 300 base
pairs upstream (left) and downstream (right) of the exon for constitutively spliced exons (green circles), alternative cassette exons (blue squares), and
species-specific exons (red triangles). (C) The relative conservation level of ESRs between human and mouse, where the X axis is the location, from the
39ss to the 59ss, in 10% increments (exon size is normalized between 0 and 1) and the Y axis is the conservation level of the wobble positions between
conserved human–mouse orthologous exons that are constitutively (yellow) and alternatively (blue) spliced in both human and mouse, or species-
specific exons (red).
doi:10.1371/journal.pgen.0030203.g001
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The experimental results validate that the exons tested are
indeed species-specific: These exons are alternatively spliced
in human and constitutively spliced in mouse (lanes H and M,
for human and mouse, respectively, Figure 2A). Moreover, the
alternative form was unique to human, as all other tested
organisms exhibited a constitutive splicing pattern (Figure
2A, lanes R, D, C, and Z, for rat, dog, chicken, and zebrafish,
respectively). Additional nonconserved spliced products were
observed (marked by open arrows), such as intron retention
and alternative 39ss usage (all PCR products were sequenced;
see Text S5 for their identity). Based on the phylogenetic
relationships among the analyzed organisms, we conclude
that the alternative splice variant is a derived form and the
constitutively spliced variant is the ancestral one.
In human, exon inclusion was the major splicing product,
and use of alternative cassette exons is the minor one for all
genes analyzed except for POLB, in which the exon inclusion/
skipping ratio was about 50% (Figure 2A). The high inclusion
level was consistent with the bioinformatic analysis (which is
one of the characteristics in Figure 1A) and with a previous
report [10]. The inclusion level analysis suggests that the
evolutionary shift from constitutive to alternative splicing
was from fully constitutively spliced exons to alternatively
spliced exons with a high inclusion level. We note that
equivalent amounts of cDNA were used in all PCR reactions
(Figure 2) and, therefore, the amounts of PCR products
presumably reflect different levels of mRNA (for example,
compare lane Z, Figure 2, between DGCR6L and TOM1).
Moreover, whenever the alternative cassette exon’s isoforms
were not detected, longer exposure of the gels did not
indicate their presence. Some of the alternative cassette
exons events generate an isoform with a premature stop
codon and we have shown that low RNA levels in human cell
lines are not due to degradation through the nonsense
mediated mRNA decay (NMD) pathway (unpublished data).
These results suggest that many species-specific AS exons
originate from ancestral constitutively spliced exons.
Exons with High Inclusion Levels Also Originate from
Constitutively Spliced Exons
To further examine the hypothesis that alternative exons
originate from ancestral constitutively spliced exons, we
selected five alternative cassette exons with a high inclusion
level conserved in human and mouse and tested their splicing
patterns in different organisms by RT-PCR analysis (Figure
2B). The relevant exon in the SLC35B3 gene was alternatively
spliced in all four mammals with a high inclusion level, but
constitutively spliced in chicken and zebrafish. Additionally,
Figure 2. Changes in the Splicing Pattern of Orthologous Exons during Evolution
(A) Schematic illustration of the bioinformatics analysis in which the orthologous exon is alternative in human and constitutive in mouse (upper panel).
The splicing pattern of five of those exons was tested in several organisms. RT-PCR analysis is shown for normal brain cDNA of human, mouse, rat, and
dog (marked H, M, R, and D, respectively), chicken (5-day-old embryos, marked as C), and adult zebrafish whole body (Z). PCR products were amplified
using species-specific primers and splicing products were separated on a 2% agarose gel and sequenced. (B) Similar analysis as in panel A, except that
the orthologous exons are alternatively spliced with a high inclusion level in both human and mouse. cDNA from Xenopus oocytes (marked X) were also
analyzed for some of the orthologs. For APGL5 (lane R), DPM1 (lane H upper band), SLC25A (lane H upper and lower bands and lane C lower band), see
Text S5. Gene names are shown on the left (see also Table S2). Arrowheads point to exon-skipping isoform; exon-inclusion isoforms are shown on the
right by black and white boxes; open arrows point to non-conserved alternatively spliced products (see Text S5).
doi:10.1371/journal.pgen.0030203.g002
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in human, mouse, and rat there is apparently an exon
repetition isoform (marked by open arrows, see Supplemen-
tal Materials, and also [30]). The alternatively spliced exon in
the TOM1 gene was detected in the Euarchontoglires (the
phylogenetic group that consists of human, mouse, and rat)
and outside this clade the exon was constitutively spliced.
Thus, this gene shows the same evolutionary pattern as the
SLC35B3 gene: constitutive splicing is the ancestral state and
alternative splicing is the derived one.
In the three other genes tested (APGL5, SLC25A, and
DPM1), alternative splicing was evident in a subset of the
tested mammals. The human and mouse exons were alter-
natively spliced in all cases, rat exons were always constitu-
tively spliced, and the dog exons were alternatively spliced in
the case of the APGL5 gene and constitutively spliced in the
others. In all cases, the splicing in nonmammalian vertebrates
was constitutive, suggesting that constitutive splicing is also
the ancestral form for these three genes. The observed
splicing pattern of the APGL5 gene in rat is due to (i) the
presence of an alternatively spliced isoform in tissues other
than the brain or under only certain environmental
conditions or (ii) a reversal in rat to the ancestral constitutive
state. Supporting the latter hypothesis of reversal is the
observation that rodent genomes are highly dynamic [31]. In
the SLC25A and DPM1 genes, alternative cassette exons were
found only in human and mouse. The alternative splicing in
rat either was not detected or has been lost. It may be that two
independent shifts from constitutive to alternative splicing
have occurred: one in the lineage leading to human and one
in the lineage leading to mouse after the rat–mouse
divergence. The ten exons evaluated (Figure 2) have shifted
their mode of splicing from constitutive to alternative during
evolution. This is consistent with the high level of similarity
found between species-specific AS exons and constitutively
spliced exons (Figure 1), which presumably reflects their
evolutionary history.
Alternatively Spliced Exons with Higher Inclusion Levels
Are More Similar to Constitutive Exons than Those with
Lower Inclusion Levels
The bioinformatics analysis and the experimental assay
suggest that some alternative cassette exons with a high
inclusion level originated from constitutively spliced exons.
Thus, we expected that alternative cassette exons with a high
inclusion level that are conserved in human and mouse are
under a different selective pressure than alternative cassette
exons with a low inclusion level. To test this hypothesis, two
groups of conserved alternative cassette exons were defined,
according to their inclusion level. The high and low inclusion
groups (HI and LI, respectively) included the upper and lower
inclusion level quartiles, respectively (inclusion level . 93.8%
and , 37.5%, respectively). We characterized these two
groups in terms of their human–mouse conservation level,
fraction of symmetrical exons, 59ss score (presented by
percent and calculated by Senapathy algorithm [32]), exon
length, Ka/Ks likelihood ratio test (Fail Ka/Ks), Ka/Ks value,
and conservation level of flanking introns. We compared
these values with those in conserved constitutively spliced
exons and alternative cassette exons. A significant difference
was found between the LI and HI groups in all tested
parameters (Figure 3; see Table S3 for the statistical analysis).
In addition, for all seven parameters tested, the average value
of the HI group was found to be more similar to
constitutively spliced exons than those of the LI group. For
example, examination of the conservation level between
human and mouse revealed that constitutively spliced exons
exhibited the lowest conservation level (87.8%). The HI group
exhibited a conservation level of 89.8%, lower than that of
the LI group (94.2%; see Figure 3A). Thus, the HI group was
more similar to constitutively spliced exons than to the LI
group. The alternative cassette exons showed intermediate
conservation levels, as expected. The same general pattern
was found with respect to the other six parameters (i.e., the
HI exons were more similar to constitutively spliced exons
than were other alternative cassette exons, and the LI exons
were less similar to constitutively spliced exons than other
alternative cassette exons were (Figure 3B–3G)). These results
are consistent with other results [24,33]. This analysis suggests
that the selection pressure acting on the LI and the HI groups
is different, with the latter being more similar to the
constitutive spliced exons group. This provides additional
support for the hypothesis that some HI exons have evolved
from constitutively spliced exons.
Fixation of Exonic Splicing Regulatory Sequences
A comparative analysis of unicellular and multicellular
eukaryotic 59ss has revealed important differences—the
plasticity of the 59ss of multicellular eukaryotes means that
these sites can be used in both constitutive and alternative
splicing and for the regulation of the inclusion/skipping ratio
in alternative splicing. So, alternative splicing might have
originated as a result of relaxation of the 59ss recognition in
organisms that originally could support only constitutive
splicing [6]. To examine the molecular evolutionary changes
required to shift exons from constitutive splicing to
alternative splicing, we analyzed the sequence of exon 5 of
the human SLC35B3 gene, which is alternatively spliced in
mammals and constitutively spliced in other vertebrates
(Figure 2B). A multiple sequence alignment of the 59ss region
of this exon from 11 vertebrates was constructed using
MAFFT [34] (Figure 4A). The 59ss of all seven mammals is
characterized by GT at positions 6 and 7. This is not typical of
mammalian 59ss: usually GT is found at positions 5 and 6 [6].
However, in all other vertebrates, there is a GT at positions 5
and 6 (AT replaces GT in zebrafish). This finding suggests two
possible scenarios: either the ancestral vertebrate had GT at
positions 5 and 6 or the ancestral vertebrate had GT at
positions 6 and 7. These scenarios correspond to an insertion
event in the lineage leading to mammals or to two deletion
events: one in the lineage leading to chicken and one in the
lineage leading to fish (Figure 4A). The deletion scenario is
less parsimonious and, hence, we speculate that an insertion
event in a mammalian ancestor was responsible for the
differential positioning of the GT in the 59ss. Can this
difference in GT location explain the observation that this
exon is alternatively spliced in mammals and constitutively
spliced in other vertebrate? This hypothesis was tested
experimentally as described below.
To examine if the molecular changes in the 59ss and the
high level of exon conservation among conserved alternative
exons are correlated, we analyzed the distribution of putative
ESRs in the sequence of this exon. We aligned this exon from
15 organisms, and identified 12 putative ESRs using the
ESEfinder [35]. Five were selected for further analysis (see also
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Tables S4 and S5). The differences in ESR sequences of
chicken and zebrafish relative to mammals considerably
change the ESR score and are, therefore, predicted to affect
splicing (these substitutions are in bold in Figure 4B; see
Tables S4 and S5). ESEfinder is based on the binding score of
human SR proteins [35]. However, it is expected that these
ESRs bind SR proteins outside the mammalian class as well
[36,37]. Our analysis revealed dynamic changes in both the
59ss and the five different potential ESRs among the
nonmammalian species and fixation of those sites among all
mammals. These changes are correlated with the transition to
alternative splicing.
To test the above observations experimentally, we cloned a
minigene containing the SLC35B3 human genomic sequence
from exon 4 through exon 6 and transfected it into human
293T cells. Total RNA was collected, followed by RT-PCR
analysis and sequencing. As shown in Figure 4C (Human
panel, lane 1 named h59ss), the exogenous wild-type (wt)
mRNA was alternatively spliced with a low inclusion level.
The difference in the inclusion level between the minigene
and the endogenous wild type (WT) mRNA (Figure 2B), might
be due to promoter differences [38]. Reconstitution of the
human 59ss to that of chicken (named c59ss) by a deletion of T
at position 4 of the human 59ss shifted splicing from
alternative to constitutive (Figure 4C, Human panel, lanes 1
and 2). This indicates that the evolutionary events differ-
entiating the chicken and the human 59ss are directly linked
to the shift from constitutive to alternative splicing. We
focused our attention on the molecular changes in the 59ss
and not the PPT/39ss region because no change was observed
in that region between constitutively and alternative cassette
exons, whereas changes were observed in the 59ss (see Text
S1).
The 59ss of zebrafish has the weakest site among the
Figure 3. High Inclusion (HI) and Low Inclusion (LI) Alternative Cassette Exons Exhibit Different Characteristics
The conserved alternative cassette exons were tested for their inclusion level. Conserved alternative cassette exons with LI and HI were compared with
conserved constitutively spliced and all alternative cassette exons: (A) exon conservation level; (B) percentage of symmetrical exons; (C) 59ss score; (D)
average length; (E) percent of exons that failed the Ka/Ks likelihood ratio test; (F) Ka/Ks value; and (G) conservation of the flanking intronic sequences.
Median conservation level at each base position was calculated for the 200 base pairs upstream (left) and downstream (right) for the CS (circle), HI
(triangle), AS (plus), and LI (square) exons.
doi:10.1371/journal.pgen.0030203.g003
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Figure 4. Mutations That Weaken the 59ss during Evolution Shift Splicing from Constitutive to Alternative
(A) Multiple alignment of the 59ss of exon 5 of the SLC35B3 gene from 11 vertebrates was constructed, substitutions were analyzed based on the known
evolutionary tree [44]. The first two intronic nucleotides are highlighted in red and evolutionary shift of the G from position 5 to 6 at the 59ss is
highlighted in purple. The gap indicates a potential insertion event. (B) Alignment of exon 5 of the SLC35B3 gene among 15 different organisms. The
first two nucleotides of intron 5 are highlighted in red (the last four species do not contain this intron). As above, the shift of the G from position 5 to 6
among those organisms in the 59ss is highlighted in purple. The examined five ESRs are highlighted in gray and marked A to E, with the name of the
putative SR protein that binds that sequence noted in the upper part of the panel. Nucleotides that are highlighted in yellow and green show exonic
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organisms evaluated, as it lacks the conserved G found at
either position 6 in mammals or at position 5 in other
vertebrates (Figure 4A). Thus, it was surprising that this
zebrafish exon is constitutively spliced (Figure 2B, SLC35B3,
lane Z). The constitutive splicing pattern in zebrafish
presumably results from the effects of ESRs rather than the
signal in the 59ss (see also [37]). Indeed when the 59ss of
human was mutated to that of zebrafish (named z59ss), it
resulted in almost total use of the alternative cassette exon
(Figure 4C, Human panel, compare lanes 10 and 16),
indicating that the zebrafish 59ss is not sufficient to generate
a constitutive splicing pattern.
We next studied the combined effect of 59ss and ESRs.
Mutating the 59ss of human to that of chicken and
reconstructing ESRs A, C, D, and E to the corresponding
chicken ESRs had no effect on splicing (Figure 4C, Human
panel, lanes 3–6). This indicates that a strong 59ss is dominant
over the effect of ESRs. However, when the 59ss is weak, ESR
mutations considerably altered splicing. This was shown by
mutations that reconstructed ESRs A–E to the zebrafish
sequences in the presence of either the zebrafish 59ss (the
weakest 59ss) or the mammalian 59ss (intermediate 59ss
strength). When the ESRs were identical to human, the
alternative splicing was observed for both the human 59ss and
the zebrafish 59ss and the level of exon inclusion was
consistent with the 59ss strength (Human panel, compare
lanes 10 and 16, respectively). Mutating the human ESRs to
those found in zebrafish under both splice sites indicated that
ESRs B and C function as enhancers, ESRs A and D as
silencers, and that ESR E had no effect (Figure 4C, Human,
lanes 10–21). This shows that ESRs A–D influence both the
human and the zebrafish 59ss.
To examine combinatorial effects of ESRs, two and three
ESRs were mutated simultaneously, using either chicken or
zebrafish 59ss. The strong 59ss of chicken was dominant over
combinatorial changes in the ESRs (Figure 4C, Human, lanes
7–9). However, when the 59ss was that of zebrafish, ESR
mutations affected splicing considerably: mutations in ESRs
AþD, AþDþE, and AþCþD enhanced the inclusion level while
mutations in BþD and AþBþCþDþE had a minor effect on the
inclusion level (Figure 4C, Human, lanes 22–26). The sum of
the scores according to the ESEfinder was predictive of the
changes in inclusion level observed by RT-PCR experiments
(see Table S4 B). This result implies a delicate combinatorial
effect among the ESRs on the splicing of an exon.
The high level of ESR conservation among mammals
implies that those sites are essential for the regulation of
the inclusion/skipping level only when the exon is alter-
natively spliced (Figure 4B–4C). However, the low conserva-
tion level of those sequences among the nonmammalian
exons might indicate that ESRs are not essential when an
exon is constitutively spliced or that the ESRs are not
functional splicing regulatory elements in nonmammalians.
To examine this, we transfected the WT and mutated
plasmids to mouse and chicken cell lines (NIH 3T3, DF-1,
respectively) and to zebrafish embryos (Figure 4C marked
Mouse, Chicken, and Zebrafish). In general, splicing patterns
were similar to that of human for the three types of 59ss and
for all mutated ESRs. For example, under the strong chicken
59ss, a constitutive pattern was observed in all species (Mouse
and Chicken panels lanes 2–9, Zebrafish panel lanes 2–3).
Similarly, ESRs B and D acted as a strong enhancer and a
strong silencer, respectively, in all species (see all panels lanes
14 and 20 for ESR D and lanes 12 and 18 for ESR B). These
findings suggest that these ESRs are active and have a similar
function in all tested cells. This further strengthens the
notion that the differences in the inclusion levels between the
mouse and the other species do not reflect divergent
evolution of splicing factors, but, rather, a different cellular
environmental effect. We note that in zebrafish the effect of
ESRs was generally weak compared with the other organisms
(compare lane 14 in all panels, see also Table S4). These
results imply that fixation of the ESRs is linked to the shift
from constitutive to alternative splicing.
The Link between a Weak 59ss and Exonic Splicing
Enhancers and Silencers
To further characterize the evolutionary processes that are
linked with the transition from a strong to a weak 59ss, the
species-specific exons were subdivided into two groups: those
in which the 59ss changed (54%, 330 out of 612 species-
specific exons) and those in which the 59ss did not change
(46%, 282 out of these 612 exons) between human and mouse.
For those exons in which the 59ss changed, a significant
decrease in 59ss strength was observed, from 83.34% to
82.02%, between constitutively and alternative cassette exons,
respectively (Mann-Whitney, p value , 0.05). Based on the
information content equation (also described in [39]) the 59ss
information content decreased from 8.25 to 7.91 bits.
However, in the group in which there was a complete
conservation of the 59ss sequence between constitutively
and alternatively spliced pairs, the average 59ss score was
already weak (82.52%), similar to the 59ss score of conserved
alternative exons (Mann-Whitney, p value ¼ 0.125). The
changes in the 59ss region between conserved constitutively
spliced exons and alternative cassette exons is shown in Text
S1 and Figure S1.
The two groups were further analyzed for their Ka/Ks ratio,
their Ks score, and their conservation level (Table S6). A
substantially higher synonymous substitution rate was found
in the group in which the 59ss changed, compared to the
group in which the 59ss did not change (v2, p value ,
1.831032 for Ks, 1.823106 for Ka, and 3.531037 for the Ka/
Ks). In addition, the conservation level (percentage of
identity) significantly differed between the two groups
(Mann-Whitney, p value , 2.73108).
To correlate these findings with creation/elimination of
exonic splicing enhancer (ESE) and exonic splicing silencer
positions that were changed during evolution (with respect to the human sequence) inside the five ESRs and outside of those sites, respectively. The
nucleotides that were mutated in our experiments are in bold (see Table S4). (C) The indicated WT and mutated SLC35B3 minigenes were transfected
into human 293T, mouse NIH 3T3, chicken DF-1 cell-lines, or injected into 1-day-old zebrafish embryos (as marked on the left). Total RNA was collected
and analyzed by RT-PCR with plasmid-specific primers and, after RT-PCR, by DNA sequencing. The two mRNA isoforms are shown on the right. Numbers
on top indicate percentage of exon inclusion as determined by ImageJ (100% corresponds to the total of both mRNA isoforms). 59ss sequences identical
to human, chicken, and zebrafish are indicated by h, c, and z, respectively.
doi:10.1371/journal.pgen.0030203.g004
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(ESS) regions, we compared the ratio between the number of
ESEs and ESSs (ESE/ESS ratio) between the species-specific
AS exons to the species-specific constitutive exons. Specifi-
cally, 238 RESCUE-ESEs [40] and 176 ESSs [41] were
separately compared for the exons pairs in which the 59ss
changed and those in which the 59ss did not change. For those
in which the 59ss changed, that ESE/ESS ratio was lower for
the alternatively spliced exons than for the constitutively
spliced ones (2.46 compared with 3.19, respectively; v2, p value
¼ 0.0026; see Table S7). No statistically significant difference
was found in the ESE/ESS ratio between species-specific
spliced alternative and constitutive exons in which the 59ss
did not change during evolution (v2, p value¼ 0.24). Next, the
difference in the ESE/ESS ratio between the two groups of
species-specific AS exons was examined. The group of
species-specific AS exons in which the 59ss changed during
evolution (i.e., decrease in 59ss affinity) showed a lower ESE/
ESS ratio compared with the group of species-specific exons
in which the 59ss did not change (2.46 compared with 2.92,
respectively; v2, p value ¼ 0.028). This indicates that the
evolutionary shift from constitutive to alternative splicing
that is manifested by mutations that weaken the 59ss is
frequently associated with changes (mostly synonymous
substitutions) in the ESE/ESS ratio in the exonic region
located upstream of the 59ss. These changes presumably
ensure proper exon recognition and regulation of the
skipping/inclusion level. To control for potential bias in our
results due to higher conservation level of the unchanged 59ss
group compared to the changed 59ss group, we repeated the
analysis by constructing two groups with identical conserva-
tion level (by cutting off the top 15% of the conserved exons
from the non-changed group and cutting the bottom 15%
from the group of the conserved exons that their 59ss was
changed); the results were similar to the results reported
above.
The Importance of the Branch Site in the Shift from
Constitutive to Alternative Splicing
The above findings suggest that mutations that weaken the
59ss during evolution are one of the mechanisms responsible
for the shift from constitutive to alternative splicing. We
hypothesize that constitutively spliced exons with a weak 59ss
may be on the verge of shifting to alternative splicing. To test
this hypothesis, we searched for constitutively spliced exons
with a weak 59ss in human and a strong 59ss in mouse or vice
versa. We found 593 cases in which the human 59ss has G at
position 5 and the mouse has G at position 6 and the opposite
in 725 cases. We selected one of these exons (exon 12 of IMP
gene, which was previously used in our lab [42]) and
constructed a multiple sequence alignment of the orthologous
exons and their flanking intronic sequences from ten
vertebrates using the M-LAGAN tool ([43], Figure 5A). The
59ss of human, chimp, rhesus, and cow are characterized by a
G at position 6, whereas in mouse and rat the G is at position
5. In dog, there is no G in positions 5 or 6 and, based on the
close phylogenetic relationship between the cow and dog 59ss
[44], we suggest that a transversion from G to C in the lineage
leading to dog is responsible for this change. It is possible that
the 59ss of mouse and rat evolved through a single deletion of
the T at position 3 of the human 59ss, which resulted in the
shifting of the G at position 6 to 5. This shift strengthens the
59ss from a score of 61.18 in human to 73.5 in mouse (based on
http://ast.bioinfo.tau.ac.il/SpliceSiteFrame.htm). The 59ss could
not be aligned reliably to the nonmammalian vertebrates.
We first validated that both the human and the mouse 59ss
are associated with constitutively spliced isoforms in a
minigene containing exons ten through 13 of the human
IMP gene (Figure 5B, lanes 1 and 2). We next tested the effect
on splicing of a single mutation in a putative BS motif on
both the human and the mouse 59ss. This putative BS was
found based on the Kol et al. algorithm that compares human
and mouse genomes [42]. The putative BS and the surround-
ing region were mutated in five different positions [42]. We
also mutated six adenosines located at the 39 end of this
intron; none of the mutations affected splicing (see Figure
S4). We mutated the conserved A in the putative BS to G
(Figure 5A). Under the 59ss of human, the mutation shifted
splicing from constitutive to alternative (lane 3). However,
under the mouse 59ss, this mutation did not change the
splicing pattern (lane 4), indicating that a strong 59ss was
dominant over mutation at the putative BS. Similar results
were obtained when a T to G mutation at position2 of the
putative BS was tested (lanes 7 and 8). A G to C mutation at
position1 of the putative BS (lanes 5 and 6, respectively) had
no effect. The mutations tested in lanes 3, 5, and 7 of Figure
5A were evaluated previously by Kol et al. [41]. The
importance of positions 1 and 2 of the putative BS [42] is
also reflected by the conservation of these positions in all
vertebrates, whereas the G at position 1 is not conserved
outside mammals (Figure 5A).
Establishing that the human exon is on the verge of
becoming alternatively spliced, we next tested whether
mutations in the putative ESRs can also shift the splicing
pattern of this exon to alternative. We previously identified
two ESRs (L and M) in this exon [29]. Deleting ESR L had no
effect on splicing under both the human and the mouse 59ss
(Figure 5B, lanes 9 and 11). However, when the deletion was
combined with the A to G mutation in the putative BS, the
inclusion level changed from 54% to 86% under the human
59ss (lane 3 versus lane 10). This indicates that ESR L is a
silencer under these conditions. However, no effect was
found for these combined mutations under the strong mouse
59ss (lane 12). Thus, ESR L affects splicing only in combina-
tion with a mutation in the putative BS motif that shifts
splicing from constitutive to alternative and only with a weak
59ss.
A point mutation in ESR M had no effect on the
constitutive recognition of that exon under either the human
and mouse 59ss (lanes 13 and 15, respectively). However, when
the ESR M mutation was combined with the A to G mutation
in the putative BS under the human 59ss, splicing was shifted
completely from alternative to use of the alternative cassette
exon (lanes 3 and 14, respectively). Therefore, under these
conditions, ESR M is a strong enhancer. The same combined
mutations under the mouse 59ss resulted in a shift to
alternative splicing (lane 16), indicating that the effect of
the strong enhancer ESR M can overcome a strong 59ss only
when the putative BS sequence is also mutated. These results
indicate that, for the tested exon, ESRs affect splicing only
when the recognition of that exon is suboptimal. In this case,
suboptimization is achieved by an interplay between a
mutated putative BS motif and the naturally weak 59ss that
flanks the human alternatively spliced exon.
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Discussion
Two models had been described for the origin of
alternative cassette exons—exonization of intronic sequences
and exon shuffling—that describe how new exons are added
to existing genes. Our results suggest a third pathway for the
evolution of alternative cassette exons: the relaxation of
constitutively spliced exons. We also suggest a molecular
mechanism for this transition: mutations weaken the splice
sites during evolution resulting in a switch from constitutive
to alternative splicing. The species-specific exons are more
similar to conserved constitutively spliced exons than to
conserved alternative cassette exons. However, they exhibit a
minor shift toward alternative cassette exons, suggesting the
shift from constitutive splicing to alternative splicing starts to
impose selective pressures, manifested in such characteristics
as the 59ss motif strength, length, etc. Given the appropriate
evolutionary period, these exons may either revert to the
constitutive splicing pattern (as the rat exon in APGL5, Figure
2B), or further progress toward alternative splicing character-
istics [24,45,46].
What is the contribution of the evolutionarily new isoforms
(alternative cassette exons) to proteome diversity? For 120
species-specific spliced exons, we found indications in
protein databases for the expression of the exon-inclusion
isoform. Both exon included and exon skipped isoforms were
found for 25 out of these 120 exons; all 25 were symmetrical
exons (Text S3; S2). This suggests that exons that recently
shifted to the mode of alternative splicing have the potential
to contribute to protein functionality. Some of these new
isoforms have been characterized: One of these is Smac3 a
novel Smac/DIABLO splicing variant, that was shown to
attenuate the stability and apoptosis-inhibiting activity of
X-linked inhibitor of apoptosis protein [47]. Another
example is the AAAS-V2, a novel splice variant of the human
AAAS gene [48]. These examples indicate that some of the new
isoforms resulting from skipping of alternative cassette exons
function in cells.
Do species-specific AS exons reflect splicing errors?
Probably some of these exons are indeed splicing errors,
reflecting the low fidelity of the spliceosome machinery
[49,50]. However, high inclusion level is not indicative that
the alternative cassette exons isoform is a nonfunctional
product, for example in SLC35B3 (Figure 2B), the low
skipping level is conserved in all mammals tested. This is
presumably indicative of functionality of the isoform without
the exon, or else the skipped isoform would not be conserved
in the mammalian class, as negative selection would act
against these events and eliminate them from the species
transcriptome. It is likely that the shift from constitutive to
alternative splicing will at first result in high inclusion levels
of the exon. With time, positive selection may increase the
Figure 5. The Effects of ESRs on Constitutive and Alternative Splicing
(A) Alignment of exon 12 of the IMP gene among 10 different organisms. The BS score and the PPT length are indicated on the left. The putative BS is in
red, with the branch-point A in uppercase. BS sites that differ from the human sequence are highlighted in gray, with the mutated nucleotides in bold.
The AG and GT of the 39 and 59ss are highlighted in green. The examined ESR sites L and M are highlighted in gray, ESR L was deleted and ESR M was
disrupted by a C to T mutation. The shift of the G from position 5 to 6 in the 59ss is highlighted in purple. Nucleotides that are highlighted in yellow and
green show exonic positions that were changed during evolution (with respect to the human sequence) inside the five ESRs and outside of those sites,
respectively. Upper and lower case indicate exonic and intronic sequence, respectively. (B) WT and mutant plasmids were introduced into 293T cells by
transfection. Total RNA was extracted and splicing products were separated on a 2% agarose gel after RT-PCR analysis. Lane 1, splicing of the WT IMP
minigene. Lanes 2 through 16, splicing products of the indicated mutants. The following abbreviations are used: m59ss indicates mutations that
reconstitute the human 59ss to that of mouse, 1BS(G.C) indicates mutation at position1 relative to the branch-point nucleotide from G to C, ESR DL
and ESR M(C.T) indicate deletion of ESR L and a point mutation from C to T in ESR M, respectively. Numbers on top indicate percentage of exon
inclusion as determined by ImageJ analysis. The two minigene mRNA products are shown on the right.
doi:10.1371/journal.pgen.0030203.g005
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fraction of the isoform without the exon within the tran-
scriptome [8,15,18]. These newcomers, the high-inclusion
exons, are the playground for future exaptation, namely, the
acquisition of a novel functionality different from their
original [45] and fixation within the human transcriptome.
Long evolutionary periods are needed for successful exapta-
tion events, and these new alternatively used exons are the
potential raw material for future evolution [15,18,45,46].
To further validate this evolutionary hypothesis, we
experimentally evaluated the splicing patterns of orthologous
exons in several vertebrates. We found that in the five tested
exons that are alternatively spliced in human but constitu-
tively spliced in mouse, the corresponding exons in all other
tested organisms were constitutively spliced. The most
parsimonious explanation of these data is that these
human-specific alternative cassette exons originated from
constitutively spliced exons. Since major shifts in the
inclusion level are probably deleterious, the newly alterna-
tively spliced exon should exhibit a high inclusion level.
Indeed, we found high inclusion levels in all exons tested,
consistent with previous studies [10].
Furthermore, the issue here is whether there exists an
evolutionary force that progressively converts constitutive to
alternative splicing during evolution. We do not believe that
this is a progressive force, because a similar number of
alternative exons in mice are constitutive in humans. This
suggests that the transition from constitutive to alternative
splicing is a random process, in which mutations that
accumulate during evolution (and other changes in the
genome) shift exons from constitutive to alternative splicing.
The fixation of the alternative form is then subjected to
purifying selection. In some diseases, for example, mutations
that shift splicing of exons from constitutive to alternative
occur, however this shift causes deleterious effects due to the
reduction of the ancestral mRNA below a certain threshold
or due to the synthesis of a dominant negative protein, and
thus the alternative form should eventually be purified from
the population. An example is Familial Dysautonomia, in
which a point mutation from T to C at position 6 of the 59ss
shifts a constitutively spliced exon to alternative splicing [51].
We anticipate that shifts in splicing are more common in
organisms containing longer introns (.500 nucleotides),
because alternatively spliced exons are generally flanked by
longer introns than are constitutive ones [4]. Therefore, a
mutation that affects exon selection in exons flanked by
longer introns might be prone to shift the exon to alternative
splicing.
The two known models for the origin of alternative cassette
exons—exonization of intronic sequences and exon shuf-
fling—describe how new exons are added to existing genes.
Our results suggest a third pathway for the evolution of
alternative cassette exons: the relaxation of constitutive
splicing. We found that inclusion levels indicate the most
plausible evolutionary scenario for the origin of alternative
cassette exons. This is based on our bioinformatic observa-
tion that alternative cassette exons with higher inclusion
levels are more similar to constitutively spliced exons than
are those with low inclusion levels.
It is currently unknown whether orthologous splicing
regulatory proteins from different organisms affect splicing
in a similar fashion in all organisms. A recent study revealed
conservation of the protein domain structure of SR proteins
across all vertebrates [52]. Moreover, recent analysis implied
that a Drosophila SR protein can also bind the corresponding
human ESR domain [36]. The effect of individual ESRs, as well
as their similar combinatorial effects on splicing, appears to
be conserved among vertebrates (Figure 4). This suggests an
important functional role of these ESRs in regulating splicing
patterns and, presumably, also a conserved functional role for
the proteins they bind, despite the ;450 million years of
evolution since the last common vertebrate ancestor. The
evolutionary insertion event in the 59ss that resulted in
weakening of the mammalian 59ss of exon 5 of SLC35B3 is the
main driving force in the shift from constitutive to alternative
splicing of this exon. Following this 59ss weakening, the ESRs
became important; a strong 59ss is not affected by the ESRs
(see also [53]). The gain of functionality of the ESRs following
the shift to a suboptimal 59ss explains the extreme increase in
ESR conservation among mammals and presumably explains
the higher conservation level of human–mouse orthologous
exons that are alternatively spliced in both species compared
to those that are constitutively spliced. The ESRs are
important for exon definition and proper regulation of the
inclusion level of alternatively spliced exons. Proper recog-
nition of constitutively spliced exons, on the other hand, is
ensured by stronger flanking splice sites, shorter flanking
introns, and longer exons than found in alternatively spliced
exon regions.
Here we demonstrated a new evolutionary pathway by
which exons shifted from constitutive to alternative splicing.
Exons that shift from constitutive to alternative splicing
generate new isoforms and become exapted. This provides a
simple mechanism to enhance transcriptomic diversification
within well-established genes, and thus plays an important
role in speciation. Although our major analysis was per-
formed on human–mouse ortholog exons that diverged about
90 million years ago, we suggest that the constitutive to
alternative splicing shift is an ancient mechanism that
governed the formation of alternative cassette exons in the
early stages of eukaryotic evolution.
Materials and Methods
Dataset compilation. A dataset of 596 alternative cassette exons,
conserved between human and mouse, was derived from a previously
compiled dataset [5]. In addition, 45,553 human–mouse conserved
constitutively spliced exons were obtained from Carmel et al. [21].
Species-specific exons were extracted from a dataset of 4,262 human–
mouse orthologous exons that are suspected to splice differentially
between human and mouse based on initial EST analysis [21].
However, not all these 4,262 exons necessarily reflected genuine
species-specific splicing cases. This might be due to rare abnormal
splicing. Thus, alternative cassette exons for which the inclusion level
was higher than 98% were removed. In addition, conserved
alternative cassette exons may be misclassified as species specific. In
such cases an alternative exon is misclassified as constitutive due to
insufficient coverage of ESTs. In other words, an exon should be
defined as constitutive only if a sufficient number of ESTs reliably
indicate that the exon is not alternatively spliced. The number of
ESTs needed depends on the inclusion level (see [21] for how
inclusion levels are computed). Modrek and Lee have shown a strong
correlation between the inclusion level of homologous alternative
cassette exons between human and mouse [8]. We assumed that if
alternative splicing was conserved for homologous exons, we would
find the same inclusion level for both species. Based on this
assumption, we computed the expected number of alternative
cassette exons for each number of ESTs. If three or more ESTs were
expected and none were observed, we rejected the hypothesis that
both exons were alternatively spliced. For example, if the alternative
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exon had an inclusion level of 90%, we would conclude that splicing
was constitutive only if none of 30 ESTs were alternatively spliced.
This is because with 30 ESTs we would expect three to support
skipping. Following these filtering steps, 612 species-specific spliced
exons remained. All datasets are available on line (http://www.tau.ac.il/
;gilast/sup_mat.htm).
Ka/Ks ratio test. In order to calculate the number of exons that
passed the Ka/Ks ratio test, we implemented the procedure of
Nekrutenko et al. [26]. We ran the codeml program from the PAML
package [54] on each exon alignment twice. First, with the Ka/Ks ratio
fixed at 1 followed by analysis with the Ka/Ks ratio as a free
parameter. We then collected the maximum likelihood values ML1
and ML2 from the two runs and calculated the likelihood ratio as LR
¼ 2(lnML1 – lnML2). Next, we compared the LR against the v2
distribution with one degree of freedom to test whether Ka/Ks was
significantly different from 1 [55].
Calculation of the flanking introns conservation level. Intron
alignment between human and mouse were calculated according to
the UCSC pairwise chained blastz alignments found in
,chrN.hg18.mm8.net.axt. files, based on the hg18 (Mars 2006) and
mm8 (Mars 2006) versions of the human and mouse genomes,
respectively. These files were downloaded from the UCSC genome
browser (http://hgdownload.cse.ucsc.edu/goldenPath/hg18/vsMm8/).
From these files the length of the intronic alignments between
human and mouse were retrieved.
Defining high and low inclusion level of alternative exons. The
conserved alternative cassette exons were divided into subgroups
according to their inclusion level. The 25% of exons with the lowest
and highest inclusion levels were defined as low inclusion (LI) and
high inclusion (HI) alternative cassette exons, respectively. These
definitions resulted in 149 HI exons with inclusion levels higher than
93.8% and 151 LI exons with inclusion levels lower than 37.5%.
Statistical analysis. The calculation of p-value was measured
according to the data distribution. The Kolmogorov-Smirnov test
was used to examine normal distribution. The T-test was used to
calculate statistical differences for p  0.05; otherwise (p value ,
0.05), the Mann-Whitney test was used for p-value calculations.
cDNA samples. We used commercial brain cDNA from human,
mouse, rat, and dog (BioChain) and prepared cDNA from different
cell lines, including human U2OS (bone osteosarcoma cells), mouse
NIH 3T3 (embryonic fibroblast cells), mouse DA-3 (mammary
carcinoma cells), and rat H4-II-E-C3 (hepatoma cells). Chicken (5-d-
old embryos) and zebrafish (adults) were disrupted in TRIzol (Sigma)
with a Polytron homogenizer (PT-MR2100 Kinematica AG, Switzer-
land). Xenopus oocytes were disrupted with a hand-held motor-pestle
(kimble-kontes, NJ). After the complete homogenization of the tissue,
total RNA extraction and reverse-transcription reaction were
performed as described in below.
Primer construction for endogenous amplification. Species-specific
primer pairs were designed using the UCSC Genome Browser [56] to
target the immediately flanking constitutive exon sequences and to
amplify an identical sized PCR product (of the exon inclusion form)
from different species. Oligonucleotide sequences will be provided
upon request.
Transient expression assay in vivo. Transient expression assays of
the pEGFP-containing constructs were performed by microinjection
of zebrafish embryos as previously described [57,58]. WT and mutant
plasmids were diluted to a final concentration of 100 ng/ll injection
solution (0.1 M KCl, 0.05% phenol red). Approximately 2 ng of plasmid
DNA were injected into the cytoplasm of one- or two-cell stage
zebrafish zygotes using a micromanipulator and a PV830 Pneumatic
Pico Pump (World Precision Instruments, Sarasota, FL, USA). Embryos
(;300) were injected with three to four different needles for each
construct. The embryos were then placed in 10 cm Petri dishes with
egg water [59] containing methylene blue (0.3 ppm) and raised in a
light- and temperature-controlled incubator (28 8C; light intensity 12
W/m2). Green fluorescence in live embryos was detected at 1 day post
fertilization under an Olympus dissecting microscope SZX12 equipped
with EGFP filter for excitation (460–490 nm) and emission (510–550
nm) (see Figure S3). pEGFP-positive embryos were collected, frozen,
and stored in liquid nitrogen prior to RNA extraction.
Plasmid constructs. The desired minigene was generated by
amplifying a human genomic fragment using PCR (Text S4). Each
primer contained an additional sequence encoding a restriction
enzyme. The PCR products were restriction digested and inserted
into the pEGFP-C3 plasmid (Clontech), subsequently the minigene
was sequenced. The first cloned minigene was from the SLC35B3 gene
(solute carrier family 35 member B3) containing exons 4 through 6
(3.1 kb). Due to size constraints that dictate what can be inserted into
this vector, we shortened the cloned fragment by deletion of 4,350
nucleotides from the middle of intron 4. This was done by amplifying
two PCR products and subcloning the fragments. The second
minigene was from the IMP gene (IGF-II mRNA-binding protein)
and contained exons 10 through 13 (2.6 kb).
Site-directed mutagenesis. Oligonucleotide primers containing the
desired mutations were used to amplify the mutation-containing
replica of the wild-type minigene plasmid. The products were treated
with DpnI restriction enzyme (12U, New England BioLabs) at 378C for
1h. From 1 to 4 ll of the mutant DNA was transformed into E. coli
XL1-competent cells. Colonies were picked and DNA purified by
Midi-prep (GENOMED). Sequences of all plasmids were confirmed by
sequencing.
Transfection, RNA isolation, and RT-PCR amplification. 293T,
NIH 3T3, DA-3, and DF-1 cell lines were cultured in Dulbecco’s
Modification of Eagle Medium, supplemented with 4.5 g/ml glucose
(Biological Industries Inc., Israel), 10% fetal calf serum (FCS), and 100
U/ml penicillin, 0.1 mg/ml streptomycin, and 1 U/ml nystatin
(Biological Industries Inc., Israel). For the DF-1 cell-line, 1.5 g/l
sodium bicarbonate was also added. Cells were cultured in 60 mm
dishes under standard conditions at 37 8C with 5% CO2. Cells were
grown to 60% confluence and transfection was performed using 3 ll
FuGENE6 (Roche) with 1 lg of plasmid DNA. After 48 h cells were
harvested. Total RNA was extracted using TRIzol Reagent (Sigma).
The injected zebrafish embryos were disrupted in TRIzol (Sigma)
using a hand-held motor-pestle (kimble-kontes, NJ). All samples were
treated with 2 U of RNase-free DNase (Ambion). Reverse tran-
scription was performed on 1–2 lg total RNA using reverse
transcribed avian myeloblastosis virus (RT-AMV, Roche) following
the manufacturer’s protocol. The spliced cDNA products derived
from the expressed minigenes were detected by PCR using Taq
polymerase (BioTools) and pEGFP-C3-specific reverse and forward
primers. Amplification was performed for 30 cycles, consisting of
denaturation for 30 s at 94 8C, annealing for 45 s at 58 8C, and
elongation for 1–2 minutes at 72 8C. The products were separated in
a 2% agarose gel. Although the RT-PCR analysis is a semi-
quantitative method, the differences between the conditions tested
here and a quantitative RT-PCR analysis are typically no more than
10% [60].
Additional methods are found in Text S6.
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